Lord, Abbett & Co. LLC Novavax Inc Transaction History

Lord, Abbett & Co. LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$134.56 - $217.97 $42.1 Million - $68.2 Million	-312,926 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$177.8 - $270.58 $55.6 Million - $84.7 Million	312,926 New	312,926 $64.9 Million
Q2 2021 Aug 11, 2021	SELL	$121.0 - $257.67 $6.06 Million - $12.9 Million	-50,061 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$112.98 - $319.93 $5.66 Million - $16 Million	50,061 New	50,061 $9.08 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $704M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.